Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M McNeil

Showing results (321-330 of 331) with videos related to

Pageof 34
Sort By:
Journal of the Pediatric Infectious Diseases Society|June 3, 2026
Association between COVID-19 Vaccination during Pregnancy and Safety among InfantsElizabeth M Quincer, Gabriela Vazquez-Benitez, Eric S Weintraub, et al.
Cancer Research|June 3, 2011
Hedgehog overexpression is associated with stromal interactions and predicts for poor outcome in breast cancerSandra A O'Toole, Dorothy A Machalek, Robert F Shearer, et al.
Histopathology|November 21, 2015
Programmed death ligand 1 expression in triple-negative breast cancer is associated with tumour-infiltrating lymphocytes and improved outcomeRhiannon K Beckers, Christina I Selinger, Ricardo Vilain, et al.
JAMA|October 2, 2008
Effects of a reduced dose schedule and intramuscular administration of anthrax vaccine adsorbed on immunogenicity and safety at 7 months: a randomized trialNina Marano, Brian D Plikaytis, Stacey W Martin, et al.
Vaccine|September 28, 2025
Clinical immunization safety assessment (CISA) project: COVID-19 vaccine consultations and case reviewsPaula M Campbell, Gabriella J Ess, Allison Lale, et al.
The Lancet. Oncology|July 22, 2017
Standard-dose pembrolizumab in combination with reduced-dose ipilimumab for patients with advanced melanoma (KEYNOTE-029): an open-label, phase 1b trialGeorgina V Long, Victoria Atkinson, Jonathan S Cebon, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 30, 2020
Five-Year Outcomes With Nivolumab in Patients With Wild-Type <i>BRAF</i> Advanced MelanomaCaroline Robert, Georgina V Long, Benjamin Brady, et al.
Vaccine|April 17, 2024
Overview of U.S. COVID-19 vaccine safety surveillance systemsJulianne Gee, Tom T Shimabukuro, John R Su, et al.
Vaccine|February 10, 2024
COVID-19 Vaccine Safety Technical (VaST) Work Group: Enhancing vaccine safety monitoring during the pandemicLauri E Markowitz, Robert H Hopkins, Karen R Broder, et al.
Vaccine|October 25, 2025
Near real-time surveillance and tree-based data mining to assess the safety of respiratory syncytial virus vaccines in older adults in the vaccine safety datalinkJames G Donahue, Noelle M Cocoros, Burney A Kieke, et al.
Pageof 34

Showing results (321-330 of 331) with videos related to

Sort By:
Pageof 34
Journal of the Pediatric Infectious Diseases Society|June 3, 2026
Association between COVID-19 Vaccination during Pregnancy and Safety among InfantsElizabeth M Quincer, Gabriela Vazquez-Benitez, Eric S Weintraub, et al.
Cancer Research|June 3, 2011
Hedgehog overexpression is associated with stromal interactions and predicts for poor outcome in breast cancerSandra A O'Toole, Dorothy A Machalek, Robert F Shearer, et al.
Histopathology|November 21, 2015
Programmed death ligand 1 expression in triple-negative breast cancer is associated with tumour-infiltrating lymphocytes and improved outcomeRhiannon K Beckers, Christina I Selinger, Ricardo Vilain, et al.
JAMA|October 2, 2008
Effects of a reduced dose schedule and intramuscular administration of anthrax vaccine adsorbed on immunogenicity and safety at 7 months: a randomized trialNina Marano, Brian D Plikaytis, Stacey W Martin, et al.
Vaccine|September 28, 2025
Clinical immunization safety assessment (CISA) project: COVID-19 vaccine consultations and case reviewsPaula M Campbell, Gabriella J Ess, Allison Lale, et al.
The Lancet. Oncology|July 22, 2017
Standard-dose pembrolizumab in combination with reduced-dose ipilimumab for patients with advanced melanoma (KEYNOTE-029): an open-label, phase 1b trialGeorgina V Long, Victoria Atkinson, Jonathan S Cebon, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 30, 2020
Five-Year Outcomes With Nivolumab in Patients With Wild-Type <i>BRAF</i> Advanced MelanomaCaroline Robert, Georgina V Long, Benjamin Brady, et al.
Vaccine|April 17, 2024
Overview of U.S. COVID-19 vaccine safety surveillance systemsJulianne Gee, Tom T Shimabukuro, John R Su, et al.
Vaccine|February 10, 2024
COVID-19 Vaccine Safety Technical (VaST) Work Group: Enhancing vaccine safety monitoring during the pandemicLauri E Markowitz, Robert H Hopkins, Karen R Broder, et al.
Vaccine|October 25, 2025
Near real-time surveillance and tree-based data mining to assess the safety of respiratory syncytial virus vaccines in older adults in the vaccine safety datalinkJames G Donahue, Noelle M Cocoros, Burney A Kieke, et al.
Pageof 34